Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Mon, 22.01.2024
Accentro Real Estate AG
Amendments to the terms and conditions of the bond successfully completed
Berlin, 22 January 2024 - On 1 December 2023, ACCENTRO Real Estate AG (the "Company") announced that the holders of the 2020/2023 bond (now 2020/2026, ISIN DE000A254YS5 / WKN A254YS - the "Bond") had approved the proposed resolution on the amendments to the terms and conditi [ … ]
Mon, 22.01.2024
Reinet Investments SCA
Reinet Investments S.C.A.’s wholly-owned subsidiary, Reinet Fund S.C.A., F.I.S., has today announced its net asset value as at 31 December 2023 as follows:
Quote
Reinet Fund S.C.A., F.I.S. (‘Reinet Fund’)
Net asset value per share as at 31 December 2023
As at 31 December 2023, the net asset value (‘NAV’) per share of Reinet Fund am [ … ]
Mon, 22.01.2024
HBM Healthcare Investments AG
Quarter under review closes with a loss of CHF 87 million. For the nine-month period, the loss totalled CHF 158 million
Unfavourable currency developments were the decisive factor
Performance is in line with relevant market indices
Unfavourable currency developments drag HBM Healthcare into the red
HBM Healthcare Investments closed the third [ … ]
Mon, 22.01.2024
Belimo Holding AG
Belimo demonstrated substantial sales growth in a year characterized by inflation pressures, rising interest rates, and slowing business momentum in the construction industry. In 2023, net sales grew 7.2% in local currencies and 1.4% in Swiss francs to CHF 858.8 million.
The Americas market region reported impressive results with a sales growth o [ … ]
Fri, 19.01.2024
BayWa AG
BayWa Supervisory Board Chairman resigns from office
BayWa Aktiengesellschaft
Public disclosure of inside information in accordance with Art. 17 MAR
Munich, 19 January 2024:
The Chairman of the BayWa Supervisory Board, Prof Klaus Josef Lutz, has today resigned from his office as a member of the Supervisory Board with immediate effec [ … ]
Fri, 19.01.2024
Blue Cap AG
Munich, January 19, 2024 – Blue Cap AG (“Blue Cap”) expects better earnings for the 2023 financial year than last assumed. According to initial preliminary calculations as part of the ongoing preparation of the consolidated financial statements for the 2023 financial year, the Blue Cap management board assumes an adjusted(1) EBITDA margin for conti [ … ]
Fri, 19.01.2024
AT&S Austria Technologie & Systemtechnik AG
AT&S corrects revenue forecast for the current financial year 2023/24
Disclosure of inside information pursuant to Article 17 MAR
Leoben – AT & S Austria Technologie & Systemtechnik Aktiengesellschaft has adjusted its revenue forecast for the current financial year 2023/24 due to lower demand caused by high inventory levels, [ … ]
Fri, 19.01.2024
Mutares SE & Co. KGaA
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, INTO OR IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER COUNTRY IN WHICH SUCH DISTRIBUTION OR PUBLICATION MAY BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE [ … ]
Fri, 19.01.2024
CoinShares Digital Securities Limited
19 January 2024
CoinShares Digital Securities Limited
Exchange Traded Products Programme for the issue of
CoinShares Digital Securities
LEI: 549300DR7967WVLR3P83
CoinShares Physical Ethereum - StakingResult of Meeting
Jersey - 19 January 2024 - This announcement is made further to the announcement made by CoinShares Digital Securi [ … ]
Fri, 19.01.2024
MediClin AG
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014Offenburg, January 19, 2024MEDICLIN close to the sale of Herzzentrum Coswig; impairment losses lead to new, adjusted forecast for 2023 MEDICLIN Aktiengesellschaft (“MEDICLIN”) is on the final stage of selling the MEDICLIN Herzzentrum Coswig, Coswig. An agre [ … ]